Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SULFAMETHOXAZOLE Cause Bladder transitional cell carcinoma? 8 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Bladder transitional cell carcinoma have been filed in association with SULFAMETHOXAZOLE (Sulfamethoxazole and Trimethoprim DS). This represents 0.2% of all adverse event reports for SULFAMETHOXAZOLE.

8
Reports of Bladder transitional cell carcinoma with SULFAMETHOXAZOLE
0.2%
of all SULFAMETHOXAZOLE reports
0
Deaths
8
Hospitalizations

How Dangerous Is Bladder transitional cell carcinoma From SULFAMETHOXAZOLE?

Of the 8 reports, 8 (100.0%) required hospitalization.

Is Bladder transitional cell carcinoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SULFAMETHOXAZOLE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does SULFAMETHOXAZOLE Cause?

Rash (2,137) Fatigue (2,096) Pyrexia (2,046) Swelling (2,024) Infection (2,018) Joint swelling (2,017) Hypersensitivity (2,000) Dyspnoea (1,984) Folliculitis (1,975) Impaired healing (1,974)

What Other Drugs Cause Bladder transitional cell carcinoma?

PIOGLITAZONE (398) ADALIMUMAB (96) METHOTREXATE (95) RITUXIMAB (74) TOCILIZUMAB (68) INFLIXIMAB (63) SULFASALAZINE (55) HYDROXYCHLOROQUINE (50) PREDNISONE (48) LENALIDOMIDE (42)

Which SULFAMETHOXAZOLE Alternatives Have Lower Bladder transitional cell carcinoma Risk?

SULFAMETHOXAZOLE vs SULFAMETHOXAZOLE\TRIMETHOPRIM SULFAMETHOXAZOLE vs SULFANILAMIDE SULFAMETHOXAZOLE vs SULFASALAZINE SULFAMETHOXAZOLE vs SULFATHIAZOLE SULFAMETHOXAZOLE vs SULFISOMIDINE

Related Pages

SULFAMETHOXAZOLE Full Profile All Bladder transitional cell carcinoma Reports All Drugs Causing Bladder transitional cell carcinoma SULFAMETHOXAZOLE Demographics